<p>The three Big Pharma companies on their earnings calls this week tried to reassure investors that they have the global footprints to mitigate the effects of tariffs.</p>

The three Big Pharma companies on their earnings calls this week tried to reassure investors that they have the global footprints to mitigate the effects of tariffs.

Editor’s (re)View: BMS, Merck, Roche see manufacturing flexibility as key to dealing with tariffs

The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing’s print and online coverage, which follows the industry’s biggest issues surrounding scale-up, technology innovations, regulations and more!

Share Editor’s (re)View: BMS, Merck, Roche see manufacturing flexibility as key to dealing with tariffs

Sign up to save your podcasts

Editor’s (re)View: BMS, Merck, Roche see manufacturing flexibility as key to dealing with tariffs

Editor’s (re)View: BMS, Merck, Roche see manufacturing flexibility as key to dealing with tariffs

More shows like Off Script: A Pharma Manufacturing Podcast

TED Radio Hour

Planet Money

The McKinsey Podcast

Odd Lots

Pivot

The Daily

Up First from NPR

The Readout Loud

The Prof G Pod with Scott Galloway

All-In with Chamath, Jason, Sacks & Friedberg

BioCentury This Week

Podnosis